The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Results from Latin America’s first PrEP demonstration project reveal that it is both feasible and effective as an HIV prevention method in the region. Will Brazil’s example pave the way for the rest of the region?
Peru is the latest country to approve the use of the antiretroviral drug, Truvada, as pre-exposure prohpylaxis (PrEP) to prevent HIV among people at a high risk of infection.
The number of babies born with HIV in Latin America and the Caribbean has decreased by 78 percent – from 10,700 in 2001, to 2,324 in 2013 – according to a new report by the Pan American Health Organization/World Health Organization (PAHO/WHO), and the United Nations Children's Fund (UNICEF). The report entitled, Elimination of Mother-to-Child Transmission of HIV and Congenital Syphilis in the Americas, documents progress made towards the 2015 goals of eliminating mother-to-child transmission (MTCT) of HIV and congenital syphilis in the region.